Login / Signup

Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry.

M Hong NguyenLuis Ostrosky-ZeichnerPeter G PappasThomas J WalshJoseph BubaloBarbara D AlexanderMarisa H MiceliJeanette JiangYi SongGeorge R Thompson
Published in: Open forum infectious diseases (2023)
species were the most commonly reported breakthrough pathogens. The discontinuation of MATs due to ADRs was infrequent. These findings support prophylactic strategies with isavuconazole, posaconazole, and voriconazole in high-risk patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • clinical trial
  • cross sectional
  • quality improvement
  • patient reported outcomes
  • study protocol